These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 9450927

  • 21. The melanocortin 1 receptor is the principal mediator of the effects of agouti signaling protein on mammalian melanocytes.
    Abdel-Malek ZA, Scott MC, Furumura M, Lamoreux ML, Ollmann M, Barsh GS, Hearing VJ.
    J Cell Sci; 2001 Mar; 114(Pt 5):1019-24. PubMed ID: 11181184
    [Abstract] [Full Text] [Related]

  • 22. Molecular interaction of Agouti protein and Agouti-related protein with human melanocortin receptors.
    Tota MR, Smith TS, Mao C, MacNeil T, Mosley RT, Van der Ploeg LH, Fong TM.
    Biochemistry; 1999 Jan 19; 38(3):897-904. PubMed ID: 9893984
    [Abstract] [Full Text] [Related]

  • 23. Inverse agonist activity of agouti and agouti-related protein.
    Chai BX, Neubig RR, Millhauser GL, Thompson DA, Jackson PJ, Barsh GS, Dickinson CJ, Li JY, Lai YM, Gantz I.
    Peptides; 2003 Apr 19; 24(4):603-9. PubMed ID: 12860205
    [Abstract] [Full Text] [Related]

  • 24. Characterization of melanocortin receptor subtype expression in murine adipose tissues and in the 3T3-L1 cell line.
    Boston BA, Cone RD.
    Endocrinology; 1996 May 19; 137(5):2043-50. PubMed ID: 8612546
    [Abstract] [Full Text] [Related]

  • 25. Biochemical and genetic studies of pigment-type switching.
    Barsh G, Gunn T, He L, Schlossman S, Duke-Cohan J.
    Pigment Cell Res; 2000 May 19; 13 Suppl 8():48-53. PubMed ID: 11041357
    [Abstract] [Full Text] [Related]

  • 26. Melanocortins and their receptors and antagonists.
    Voisey J, Carroll L, van Daal A.
    Curr Drug Targets; 2003 Oct 19; 4(7):586-97. PubMed ID: 14535656
    [Abstract] [Full Text] [Related]

  • 27. Chimeric NDP-MSH and MTII melanocortin peptides with agouti-related protein (AGRP) Arg-Phe-Phe amino acids possess agonist melanocortin receptor activity.
    Joseph CG, Wilczynski A, Holder JR, Xiang Z, Bauzo RM, Scott JW, Haskell-Luevano C.
    Peptides; 2003 Dec 19; 24(12):1899-908. PubMed ID: 15127941
    [Abstract] [Full Text] [Related]

  • 28. Agouti antagonism of melanocortin binding and action in the B16F10 murine melanoma cell line.
    Blanchard SG, Harris CO, Ittoop OR, Nichols JS, Parks DJ, Truesdale AT, Wilkison WO.
    Biochemistry; 1995 Aug 22; 34(33):10406-11. PubMed ID: 7544613
    [Abstract] [Full Text] [Related]

  • 29. Syndecan-3 modulates food intake by interacting with the melanocortin/AgRP pathway.
    Reizes O, Benoit SC, Strader AD, Clegg DJ, Akunuru S, Seeley RJ.
    Ann N Y Acad Sci; 2003 Jun 22; 994():66-73. PubMed ID: 12851299
    [Abstract] [Full Text] [Related]

  • 30. The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation.
    Cone RD, Lu D, Koppula S, Vage DI, Klungland H, Boston B, Chen W, Orth DN, Pouton C, Kesterson RA.
    Recent Prog Horm Res; 1996 Jun 22; 51():287-317; discussion 318. PubMed ID: 8701084
    [Abstract] [Full Text] [Related]

  • 31. Melanocortin receptor-mediated mobilization of intracellular free calcium in HEK293 cells.
    Mountjoy KG, Kong PL, Taylor JA, Willard DH, Wilkison WO.
    Physiol Genomics; 2001 Feb 07; 5(1):11-9. PubMed ID: 11161002
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Regulation of adipose tissue leptin secretion by alpha-melanocyte-stimulating hormone and agouti-related protein: further evidence of an interaction between leptin and the melanocortin signalling system.
    Hoggard N, Hunter L, Duncan JS, Rayner DV.
    J Mol Endocrinol; 2004 Feb 07; 32(1):145-53. PubMed ID: 14765998
    [Abstract] [Full Text] [Related]

  • 34. Agouti protein can act independently of melanocyte-stimulating hormone to inhibit melanogenesis.
    Hunt G, Thody AJ.
    J Endocrinol; 1995 Nov 07; 147(2):R1-4. PubMed ID: 7490543
    [Abstract] [Full Text] [Related]

  • 35. Effects of melanocortin receptor ligands on thyrotropin-releasing hormone release: evidence for the differential roles of melanocortin 3 and 4 receptors.
    Kim MS, Small CJ, Russell SH, Morgan DG, Abbott CR, alAhmed SH, Hay DL, Ghatei MA, Smith DM, Bloom SR.
    J Neuroendocrinol; 2002 Apr 07; 14(4):276-82. PubMed ID: 11963824
    [Abstract] [Full Text] [Related]

  • 36. Molecular basis for the interaction of [Nle4,D-Phe7]melanocyte stimulating hormone with the human melanocortin-1 receptor.
    Yang Yk, Dickinson C, Haskell-Luevano C, Gantz I.
    J Biol Chem; 1997 Sep 12; 272(37):23000-10. PubMed ID: 9287296
    [Abstract] [Full Text] [Related]

  • 37. Interaction of melanin-concentrating hormone (MCH), neuropeptide E-I (NEI), neuropeptide G-E (NGE), and alpha-MSH with melanocortin and MCH receptors on mouse B16 melanoma cells.
    Hintermann E, Tanner H, Talke-Messerer C, Schlumberger S, Zumsteg U, Eberle AN.
    J Recept Signal Transduct Res; 2001 Feb 12; 21(1):93-116. PubMed ID: 11693176
    [Abstract] [Full Text] [Related]

  • 38. Regulation of melanocortin 1 receptor expression at the mRNA and protein levels by its natural agonist and antagonist.
    Rouzaud F, Annereau JP, Valencia JC, Costin GE, Hearing VJ.
    FASEB J; 2003 Nov 12; 17(14):2154-6. PubMed ID: 14500544
    [Abstract] [Full Text] [Related]

  • 39. Structure-activity relationship of (1-aryl-2-piperazinylethyl)piperazines: antagonists for the AGRP/melanocortin receptor binding.
    Arasasingham PN, Fotsch C, Ouyang X, Norman MH, Kelly MG, Stark KL, Karbon B, Hale C, Baumgartner JW, Zambrano M, Cheetham J, Tamayo NA.
    J Med Chem; 2003 Jan 02; 46(1):9-11. PubMed ID: 12502354
    [Abstract] [Full Text] [Related]

  • 40. Inverse agonism gains weight.
    Adan RA, Kas MJ.
    Trends Pharmacol Sci; 2003 Jun 02; 24(6):315-21. PubMed ID: 12823958
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.